packageSevabertinib

sevabertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sevabertinib is an anti-cancer medicine used to treat non-small cell lung cancer. It is a HER2 tyrosine kinase inhibitor with approved and investigational status, but no European Union authorisation is recorded.

Summary written by glm-5.3-flash from Wikidata Q137258574 and the WHO ATC classification; not checked by a person.

name:sevabertinib
ATC codes:L01EH06
DrugBank:DB21667
PubChem CID:155234713
Wikidata:Q137258574
formula:C24H25ClN4O5
molar mass:484.937 g/mol (PubChem CID 155234713)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown